Watch this video to learn how to inject Emgality

Indications and Important Safety Information
Indication

Emgality is indicated for the preventive treatment of migraine in adults.

Important Safety Information about Emgality (galcanezumab-gnlm)

Do not use Emgality if you are allergic to galcanezumab-gnlm or any of the ingredients in Emgality.


Emgality may cause serious side effects, including: allergic reactions, such as itching, rash, hives, and trouble breathing. Allergic reactions can happen days after using Emgality. Call your healthcare provider or get emergency medical help right away if you have any of the following symptoms, which may be part of an allergic reaction:

  • swelling of your face, mouth, tongue, or throat
  • trouble breathing

Before you use Emgality, tell your healthcare provider if you are:

  • pregnant or plan to become pregnant. It is not known if Emgality will harm your unborn baby
  • breastfeeding or plan to breastfeed. It is not known if Emgality passes into breast milk
  • taking any prescription or over-the-counter medicines, vitamins, or herbal supplements

The most common side effects of Emgality include: Injection site reactions


Tell your healthcare provider if you have any side effect that bothers you or does not go away. These are not all the possible side effects of Emgality. For more information, ask your healthcare provider or pharmacist.


You can report side effects to the Food and Drug Administration (FDA) at www.fda.gov/medwatch or by calling 1-800-FDA-1088.


Emgality is available by prescription only.


Please see Prescribing Information, including Patient Information, for Emgality. See Instructions for Use included with the pen and prefilled syringe.


GZ CON ISI 27SEP2018